JBF Capital »

Arbutus Biopharma shares owned by JBF Capital

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by JBF Capital from 13F filings

Historical chart of JBF Capital investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by JBF Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by JBF Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $361k 80k 4.50

More positions owned by JBF Capital

Vanguard S&p 500 Etf Etf (VOO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Green Brick Partners (GRBK)
Goldman Sachs (GS)
State Street Spdr S&p Biotech Etf Etf Etf (XBI)
Facebook Inc cl a (META)
Netflix (NFLX)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Lowe's Companies (LOW)
Commercial Bancgroup (CBK)
NVIDIA Corporation (NVDA)
Korea (KF)
GSK (GSK)

View all positions for JBF Capital

Top funds holding Arbutus Biopharma

Morgan Stanley
Two Seas Capital
Whitefort Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Rubric Capital Management
State Street Corporation
Adage Capital Partners GP
Geode Capital Management
ADAR1 Capital Management
Legal & General Group
Woodline Partners
Leucadia National Corporation
BlackBarn Capital Partners

View all funds holding Arbutus Biopharma